Three routes reach the epidural space, and they are not interchangeable. The approach is chosen from where the pain is, what the imaging shows, and what surgery the patient has already had.
This guide sets out how each is performed, when it is preferred, and when it is ruled out — drawing on the teaching of Dr. María Alejandra De La Peña, an anaesthesiologist fellowship-trained in interventional pain management.
The symptom pattern decides it
Before imaging, before anything else, the distinction is whether the pain is in the back, in the leg, or both.
Back and leg pain together points to an interlaminar approach. De La Peña's rule: “if it's back and leg, it's better to start with a lumbar interlaminar epidural injection.”
Leg pain alone points to a transforaminal approach. In her words: “if the patient goes to your office and tells you, I only have sciatica, then a selective nerve root block, transforaminal epidural approach, is a better option to treat this problem.”
The logic is one of coverage. A broad delivery suits a broad problem; a single irritated root is better served by medication placed at that root.
Interlaminar epidural injection
The needle passes between the laminae in the midline, through the supraspinous and interspinous ligaments and then the ligamentum flavum, where loss of resistance signals entry to the epidural space.
Medication spreads across several levels rather than concentrating at one, which is why it suits axial pain with a radicular component. It is the more familiar approach to most clinicians, and the one for which a particulate depot steroid such as triamcinolone is recommended.
When it is ruled out: after a laminectomy. The bony landmark it depends on has been removed and the anatomy is distorted. De La Peña is direct — interlaminar “is not recommended because the patient has a laminectomy, so the anatomy is distorted and there is a high risk of having intrathecal uptake.”
Transforaminal epidural steroid injection
This is a selective nerve root technique. The needle is directed to the neural foramen where a specific root exits, and medication is delivered to that root.
Its advantages are precision and diagnostic value: a good response localises the symptomatic level, which matters if surgery is being considered. It is also the approach used where previous surgery has made the midline unusable, and it can be performed bilaterally where both sides are symptomatic.
The steroid choice changes here, and the reason is anatomical. Non-particulate steroid is safer for transforaminal work “because of all the structures that are surrounding, including nerves and arteries.” The foramen carries radicular arteries, and a particulate suspension entering one cannot pass through it. Dexamethasone is the standard choice, accepting a shorter duration of action for the reduced risk.
Dosing runs roughly half that used for interlaminar — around 40 mg against 40 to 80 mg.
Caudal epidural injection
The caudal approach enters through the sacral hiatus at the very base of the spine, below the level at which the dura ends. That anatomical fact is its principal safety advantage: the risk of dural puncture is substantially lower.
Its distinctive indication is the post-surgical spine. De La Peña describes patients “fused all the way down to L5-S1” who “develop a lot of adhesions”, where “these injections on this approach with a catheter will help release the tissue and improve the pain of the patient.” A catheter threaded from below can reach scarred territory that a direct approach cannot.
The tradeoff is volume and dilution: medication is delivered further from the target and spreads more diffusely.
How previous surgery redirects the choice
Surgical history is not a footnote in the consent form. It is frequently what determines the approach.
- Laminectomy — interlaminar is out, distorted anatomy and intrathecal uptake risk. Transforaminal instead.
- Fusion with adhesions — caudal with a catheter, to reach and release scarred tissue.
- Multi-level laminectomy — expect lateral recess stenosis, facet arthropathy and bone spurs to have developed, which changes the target rather than removing it.
De La Peña is realistic about what happens afterwards in this group: a patient may have “good initial response from this surgery, but over time with the degeneration he will have recurrence.” That belongs in the conversation before the injection, not after.
What confirms the needle is where it should be
Every approach shares the same confirmation sequence, and skipping any part of it is where harm originates.
- Loss of resistance through the ligamentum flavum, using air or saline.
- Aspiration to confirm neither blood nor cerebrospinal fluid returns. If either does, the needle is repositioned — not adjusted and used.
- Contrast under fluoroscopy to confirm the spread pattern matches the intended target.
De La Peña's reason for insisting on contrast is the consequence of proceeding without it: steroid delivered into the intrathecal space can cause arachnoiditis and nerve damage. Contrast, she says, “is extremely important to avoid complications.”
Fluoroscopic spread also reads diagnostically. She describes a case in which the contrast pattern crossed the expected anatomical line, revealing that part of the patient's stenosis was caused by ligamentum flavum hypertrophy — information the injection itself produced.
The three approaches compared
| Interlaminar | Transforaminal | Caudal | |
|---|---|---|---|
| Best for | Back and leg pain together | Leg pain alone, single root | Post-surgical adhesions, multi-level |
| Spread | Broad, several levels | Targeted to one root | Diffuse, from below |
| Steroid | Particulate acceptable | Non-particulate preferred | Either, volume-dependent |
| Dural puncture risk | Present | Lower | Lowest |
| Ruled out by | Laminectomy at that level | — | Sacral anatomy variants |
Learn blocks with your hands, not from a page
Empire’s Pain Management Training (THE Pain Show) is accredited for 25.25 AMA PRA Category 1 Credits™, jointly provided by AKH, Inc, and Empire Medical Training. For narrower peripheral work, Joint, Extremity and Non-Spinal Injection Training carries 6.75 credits for the complete in-person hybrid program, and Advanced Musculoskeletal Ultrasound Guided Injections builds the guidance skills above.



